| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 12/08/2004 | EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth | 
| 12/08/2004 | EP1484064A1 Therapeutical composition containing dentritic cells and use thereof | 
| 12/08/2004 | EP1484063A2 Method for inhibiting rejection of transplanted tissue | 
| 12/08/2004 | EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders | 
| 12/08/2004 | EP1483398A2 Method for producing riboflavin | 
| 12/08/2004 | EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing | 
| 12/08/2004 | EP1483390A2 Transgenic plants synthesising high amylose starch | 
| 12/08/2004 | EP1483389A2 Genetic products differentially expressed in tumors and use thereof | 
| 12/08/2004 | EP1483384A2 Method for overexpression of zwitterionic polysaccharides | 
| 12/08/2004 | EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof | 
| 12/08/2004 | EP1483380A2 Recombinant protein c variants | 
| 12/08/2004 | EP1483374A2 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo | 
| 12/08/2004 | EP1483373A2 Surgical device for skin therapy or testing | 
| 12/08/2004 | EP1483372A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions | 
| 12/08/2004 | EP1483371A1 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues | 
| 12/08/2004 | EP1483370A2 Hepatocyte precursor cell lines | 
| 12/08/2004 | EP1483369A1 Avian cell lines for the production of useful substances | 
| 12/08/2004 | EP1483368A2 In vitro maturation of immature human oocytes | 
| 12/08/2004 | EP1483298A2 Materials and methods for preparing dimeric growth factors | 
| 12/08/2004 | EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature | 
| 12/08/2004 | EP1483296A1 Specific ab1'-antibodies against tumour-associated antigen ca 125 | 
| 12/08/2004 | EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof | 
| 12/08/2004 | EP1483288A2 Hbm variants that modulate bone mass and lipid levels | 
| 12/08/2004 | EP1482956A1 Targeted drug delivery methods | 
| 12/08/2004 | EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto | 
| 12/08/2004 | EP1482916A2 Schwann cell and phosphodiesterase inhibitors based therapy | 
| 12/08/2004 | EP1482871A2 Artificial vessel scaffold and artificial organs therefrom | 
| 12/08/2004 | EP1482807A2 Food fermentation with lactic acid bacteria | 
| 12/08/2004 | EP1482788A2 Compositions comprising reproductive cell media and methods for using such compositions | 
| 12/08/2004 | EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells | 
| 12/08/2004 | EP1482779A2 Heat stable mutants of starch biosynthesis enzymes | 
| 12/08/2004 | EP1444345A4 Conversion of liver stem and progenitor cells to pancreatic functional cells | 
| 12/08/2004 | EP1390754A4 Method and composition for skin grafts | 
| 12/08/2004 | EP1150694B1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same | 
| 12/08/2004 | EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation | 
| 12/08/2004 | EP1115433B1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same | 
| 12/08/2004 | EP1056858B1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3) | 
| 12/08/2004 | EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | 
| 12/08/2004 | EP0991402B1 Process for preparing a poly(vinyl alcohol) cryogel | 
| 12/08/2004 | EP0782628B1 Improvement of an expression vector for production of recombinant proteins | 
| 12/08/2004 | EP0711353B1 Production of trehalose in plants | 
| 12/08/2004 | CN1554025A Cell-based detection and differentiation of disease states | 
| 12/08/2004 | CN1553963A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells | 
| 12/08/2004 | CN1553962A System for detecting protease | 
| 12/08/2004 | CN1553961A Membrane virus host range mutations and their uses as vaccine substrates | 
| 12/08/2004 | CN1553958A Photochemical internalization for delivery of molecules into the cytosol | 
| 12/08/2004 | CN1553952A Materials and methods to promote repair of nerve tissue | 
| 12/08/2004 | CN1553951A Human cord blood derived unrestricted somatic stem cells (USSC) | 
| 12/08/2004 | CN1553950A Method for increasing stress tolerance in plants | 
| 12/08/2004 | CN1553919A Shrimp alkaline phosphotase | 
| 12/08/2004 | CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B | 
| 12/08/2004 | CN1553812A 自体t-细胞疫苗材料和方法 Autologous vaccines Materials and Methods Cell t- | 
| 12/08/2004 | CN1553793A Hair follicle neogenesis by injection of follicle progenitor cells | 
| 12/08/2004 | CN1552877A Use and constructing method for anticancer recombined gland virus with tumour cell PLK1 as target of medicine | 
| 12/08/2004 | CN1552856A DNA encoding a plasminogen-activating protein | 
| 12/08/2004 | CN1552855A Vascular endothelial growth factor 2 | 
| 12/08/2004 | CN1552854A Gene of coding cobweb protein and use thereof | 
| 12/08/2004 | CN1552853A Preparation of hybrid tumour cell expression gene engineering urokinase zymogen | 
| 12/08/2004 | CN1552851A False virus of SARS coronavirus and its preparation and use | 
| 12/08/2004 | CN1552849A Transgenic plants expressing cellulolytic enzymes | 
| 12/08/2004 | CN1552848A CIK cell external culturing method | 
| 12/08/2004 | CN1179048C Modified MSP-1 nucleic acid sequences and method for increasing mRN-A level and protein expression in cell system | 
| 12/08/2004 | CN1179047C Method for introducing substances into cells and use of said method | 
| 12/08/2004 | CN1179041C Improved phytases | 
| 12/08/2004 | CN1179040C Cyclic peptides | 
| 12/08/2004 | CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA | 
| 12/08/2004 | CN1178952C Nucleic acids encoding G-protein coupled receptor involved in sensory transduction | 
| 12/08/2004 | CN1178950C Corpuscles of stannius protein and stanniocalcin | 
| 12/07/2004 | US6828493 Wheat variety 25R47 | 
| 12/07/2004 | US6828491 Suppression of specific classes of soybean seed protein genes | 
| 12/07/2004 | US6828477 Method of enhancing endosperm development in a plant | 
| 12/07/2004 | US6828473 Transgenic mammal for use in the treatment of cancer and inflammatory disease | 
| 12/07/2004 | US6828430 For prognosis/treatment; poly(A) binding protein II (PAB II) | 
| 12/07/2004 | US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent | 
| 12/07/2004 | US6828420 Small conductance, calcium-activated potassium channels (SKI) | 
| 12/07/2004 | US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same | 
| 12/07/2004 | US6828357 Polyhydroxyalkanoate compositions having controlled degradation rates | 
| 12/07/2004 | US6828150 Antigen presenting system and methods for activation of T-cells | 
| 12/07/2004 | US6828149 Diagnosis of disease; screening antibodies | 
| 12/07/2004 | US6828148 Miniribozymes active at low magnesium ion concentrations | 
| 12/07/2004 | US6828147 Method of modifying cytotoxic cells and uses thereof | 
| 12/07/2004 | US6828145 Selecting cells that express a known marker, such as proteins expressed by genes encoding the major histocomatibility complex | 
| 12/07/2004 | US6828133 Recombinant vanadium haloperoxidases and their uses | 
| 12/07/2004 | US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases | 
| 12/07/2004 | US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases | 
| 12/07/2004 | US6828117 Alzheimer's disease secretase, APP substrates therefor, and uses therefor | 
| 12/07/2004 | US6828114 Monoclonal antibody against apolipoprotein A-I | 
| 12/07/2004 | US6828111 Apparatus for propagation, diagnosis, evalation and analysis of potentially tumorous tissues; antitumor agents; anticarcinogenic agents | 
| 12/07/2004 | US6828099 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression | 
| 12/07/2004 | US6828095 Modulators of morphogen expression and methods of identifying the same | 
| 12/06/2004 | CA2469992A1 Transgenic animal model for glyt1 function | 
| 12/02/2004 | WO2004104549A2 Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics | 
| 12/02/2004 | WO2004104200A1 Method of controlling cell proliferation by using novel function of myeloid leukemia factor mlf1 and utilization of the same | 
| 12/02/2004 | WO2004104195A1 Insulin-producing cells and method of constructing the same | 
| 12/02/2004 | WO2004104188A1 Method for the in vitro production of cartilage-like tissue | 
| 12/02/2004 | WO2004104187A1 Fibroblast and method of culturing the same | 
| 12/02/2004 | WO2004104186A1 Restricted glucose feed for animal cell culture | 
| 12/02/2004 | WO2004104185A1 Generation and isolation of antigen-specific t cells | 
| 12/02/2004 | WO2004104184A1 Preparation of endodermal stem cells | 
| 12/02/2004 | WO2004104183A2 Method for the in vitro production of cartilage-like tissue |